Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BIO-CSF LIQUID CONTROL LEVEL 1 AND 2

K-Number: K963551 · 1996-10-07

ApplicantBiocell Laboratories, Inc.
Decision Date1996-10-07
Product CodeJJX
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

BIO-CSF LIQUID CONTROL LEVEL 1 AND 2 is the device name listed in this FDA 510(k) record. The listed applicant is Biocell Laboratories, Inc.. It received FDA 510(k) clearance on 1996-10-07 under 510(k) number K963551. The device is classified under product code JJX. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BIO-CSF LIQUID CONTROL LEVEL 1 AND 2?

BIO-CSF LIQUID CONTROL LEVEL 1 AND 2 is a medical device that received FDA 510(k) clearance on 1996-10-07. The listed applicant is Biocell Laboratories, Inc.. The 510(k) number is K963551.

When did BIO-CSF LIQUID CONTROL LEVEL 1 AND 2 receive FDA 510(k) clearance?

BIO-CSF LIQUID CONTROL LEVEL 1 AND 2 received FDA 510(k) clearance on 1996-10-07, under 510(k) number K963551.

Who is the listed applicant for BIO-CSF LIQUID CONTROL LEVEL 1 AND 2?

The FDA 510(k) record lists Biocell Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BIO-CSF LIQUID CONTROL LEVEL 1 AND 2?

The FDA product code for BIO-CSF LIQUID CONTROL LEVEL 1 AND 2 is JJX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Biocell Laboratories, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K000056BIO-LIPID HUMAN SERUM HDL AND LDL CALIBRATORSK951749BIO-LIPID LIPID CONTROL- LEVEL 1,2 AND 3K844344GEMCAL ENI REFERENCE SERUMK830911RADIAL IMMUNODIFFUSION PLATESK830179BIOCELL SPINAL FLUID CONTROL

Related Devices (Code: JJX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K170678Beta-CrossLaps CalCheck 5Roche DiagnosticsK162173Elecsys CYFRA 21-1 CalCheck 5Roche DiagnosticsK162514Multichem A1cTechnopath ManufacturingK161874Audit MicroControls Linearity DROP LQ Blood GlucoseAalto Scientific, Ltd.K161526LIAISON CMV IgM Serum Control SetDiaSorin, Inc.K161522LIAISON EBV IgM Serum Control SetDiaSorin, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑